medigraphic.com
ISSN 2218-6719 (Print)

2019, Number 3

<< Back

Rev Cub de Tec de la Sal 2019; 10 (3)

Double acromegaly? Case report

Boffill CS, Valdés LN, Fernández GS, Pereda PM

Language: Spanish
References: 11
Page: 117-123
PDF size: 438.78 Kb.


ABSTRACT

What the case brings again?: the interesting contribution of this case is the infrequent association between bronchial carcinoid tumor and pituitary macrotumor, both producers of growth hormone and responsible for the genesis of overt acromegaly in this patient. We present a clinical case of a female patient diagnosed with a left bronchial carcinoid tumor in 2006 in the pneumology department of the Hermanos Ameijeiras Hospital with paraneoplastic manifestations of acromegaly, which re-enters at 10 years of age with recurrence of manifestations of the endocrine disease. It was initially attributed to the lung injury. Main clinical symptoms: respiratory manifestations due to dyspnea, cough and hemoptoic sputum. Main clinical signs: acromegaloidea fascia, enlarged hands and feet and sausage fingers. Diagnoses: left bronchial carcinoid tumor and pituitary adenoma producing GH, which underwent left pneumectomy in 2006 and pituitary adenomectomy in 2018 respectively. Relevant results: regression of the clinical picture, decrease in GH levels and absence of tumor lesion in the imaging studies. Conclusions: the association between two concomitant clinical entities responsible for acromegaly is little known in the medical literature.


REFERENCES

  1. Hayward BE, Barlier A, Korbonits M, Grossman AB, Jacquet P, Ent A, et al. Imprinting of the Gs alpha gene GNAS1 in the pathogenesis acromegaly. J Clin Invest. [Internet] 2014 [consultado 2 Apr 2019]; 6 (31): [aproximadamente 24 p] Disponible en: https://www.ncbi.nlm.nih.gov

  2. Weiss J, Wood A, Zajac J, Grossmann M, Andrikopoulos S, Ekinci E. Diabetic ketoacidosis in acromegaly; a rare complication precipitated by corticosteroid use. Diabetes Research and Clinical Practice. [Internet] 2017 [consultado 6 March 2019]; 30(8): [20p] Disponible en: https://www.diabetesresearchclinicalpractice.com

  3. Arellano S, Aguilar P, Mercado M, Vergara A. Consenso nacional de acromegalia: Recomendaciones para su diagnóstico, tratamiento y seguimiento. Endocrinología y nutrición 2017; 15:S7-S16.

  4. Melmed S. Etiology of pituitary acromegaly. Endocrinol Metab Clin North Am [Publicación periódica en línea] 2016 [consultado 17 Janua 2019]; 21(6): [51p] Disponible en: https://www.sciencedirect.com>pii

  5. Fernández-Rodríguez E, Bernabeu I, Casanueva FF. Hipopituitarismo. Panhipopituitarismo. Medicine. [Publicación periódica en línea] 2015 [consultado 7 Feb 2019]; 11(13) : [81p] Disponible en: https://www.medicineonline.es>es

  6. Sanchez G. Acromegalia: epidemiologia, manifestaciones clínicas, diagnóstico y tratamiento. Clínica de endocrinología y metabolismo. Universidad de la Republica, Montevideo, Uruguay 2016:1-13.

  7. Muñoz del Castillo F y Jurado Ramos A. Abordaje endoscópico transeptal de los tumores hipofisarios. [Internet] 2017 [consultado 6 March 2019]; 4(54): [50p] Disponible en: https://sciencedirect.com>pii>pdf

  8. Molitch ME. Pituitary Incidentalomas. Functional and morphological imaging of the endocrine system. [Internet] 2016 [consultado 7 Feb 2019]; 5(9): [70p] Disponible en: https://www.ncbi.nlm.nih.gov>pub

  9. Harrison T. R, Fauci A. S, Kasper D. L, Hauser S. L, Jameson J. L, Lozcalzo J, et al. Trastornos de la adenohipófisis y el hipotálamo. Harrison Principios de Medicina Interna. 18th ed. The McGraw-Hill Companies, Inc., New York, N.Y. USA. Silverchair. 2012; 186.70.61.231.

  10. Bidlingmaier M, Strasburger C. Growth hormone assays: current methodologies and their limitations. Pituitary. [Internet] 2007 [consultado 7 Feb 2019]; 10 (2): [aproximadamente 60p] Disponible en: https://www.ncbi.nlm.nih.gov>m

  11. Nedel Valdés Lorenzo. Protocolización de la Asistencia Médica. La Habana. Ciencias Médicas. 2015; 405.




2020     |     www.medigraphic.com